Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Veracyte (VCYT)
NASDAQ:VCYT
Veracyte (VCYT) Stock Price & Analysis
407 Followers
VCYT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.92 - $32.40
Previous Close$22.6
Volume439.06K
Average Volume (3M)580.29K
Market Cap
$1.64B
Enterprise ValueN/A
Total Cash (Recent Filing)$191.14M
Total Debt (Recent Filing)$14.86M
Price to Earnings (P/E)-56.0
Beta1.97
Next Earnings
Oct 31, 2023EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding72,750,543
10 Day Avg. Volume556,869
30 Day Avg. Volume580,293
Standard Deviation0.19
R-Squared0.15
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)8.08
Price to Sales (P/S)18.20
Price to Cash Flow (P/CF)-52.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$31.67Price Target Upside40.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Veracyte News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VCYT FAQ
What was Veracyte’s price range in the past 12 months?
Veracyte lowest stock price was $14.92 and its highest was $32.40 in the past 12 months.
What is Veracyte’s market cap?
Currently, no data Available
When is Veracyte’s upcoming earnings report date?
Veracyte’s upcoming earnings report date is Oct 31, 2023 which is in 38 days.
How were Veracyte’s earnings last quarter?
Veracyte released its earnings results on Aug 08, 2023. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.152 by $0.032.
Is Veracyte overvalued?
According to Wall Street analysts Veracyte’s price is currently Undervalued.
Does Veracyte pay dividends?
Veracyte does not currently pay dividends.
What is Veracyte’s EPS estimate?
Veracyte’s EPS estimate is -$0.15.
How many shares outstanding does Veracyte have?
Veracyte has 72,750,540 shares outstanding.
What happened to Veracyte’s price movement after its last earnings report?
Veracyte reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.152. Following the earnings report the stock price went up 7.04%.
Which hedge fund is a major shareholder of Veracyte?
Among the largest hedge funds holding Veracyte’s share is ARK Investment Management LLC. It holds Veracyte’s shares valued at 199M.
---
Veracyte Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.67 (40.94% Upside)
$31.67 (40.94% Upside)
Blogger Sentiment
Bullish
VCYT Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 631.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 1.3%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.55%
12-Months-Change
Fundamentals
Return on Equity
-2.71%
Trailing 12-Months
Asset Growth
1.48%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Veracyte
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding VCYT
Vanguard Total Stock Market ETF
$58.56M
Vanguard Health Care ETF
$6.64M
Schwab U.S. Broad Market ETF
$884.90K
Fidelity Nasdaq Composite Index ETF
$510.21K
Vanguard Russell 3000 ETF
$120.70K
Up to five ETFs with an Outperform Smart Score that hold VCYT. The ETFs are listed according to market value of VCYT within the ETF
---